Serum CA125: a prognostic biomarker for mortality in chronic heart failure
Our findings suggest that serum CA125 levels may serve as a potential prognostic biomarker for mortality in CHF patients, particularly in the HFpEF subgroup. However, further research is needed to confirm these findings and elucidate the underlying mechanisms.
Authors
- Aihaidan Abudouwayiti (ORCID: https://orcid.org/0000-0002-3945-9973)
- Lijuan Ma
- Ying Pan (ORCID: https://orcid.org/0000-0002-8744-6931)
- Ailiman Mahemuti (ORCID: https://orcid.org/0000-0002-9174-5678)
- Ying-Ying Zheng (ORCID: https://orcid.org/0000-0001-5587-9911)
- Salamaiti Aimaier
- Yan Li (ORCID: https://orcid.org/0000-0002-3713-1237)
- Zhi‐Ying Wen
- Ruzeguli Tuersun
- Wei-Tong Gao
Institutions
- Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1186/s12872-025-04685-w
- Citations
- 9
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 12.49